Adalvo is thrilled to be making remarkable strides in the world of diabetic care. With an unwavering commitment to patient well-being, Adalvo proudly stands alone as the sole B2B company capable of offering a comprehensive diabetes product line, encompassing both injectables and oral.
Diabetes is a global healthcare challenge, and Adalvo is at the forefront, addressing this pressing issue with a holistic approach.
We have become a one-stop-shop solution for partners looking for diabetes products, offering a basket of seven dossiers, at a combined global market size of $54BN, with a CAGR of 26% (according to IQVIA).
Our dossiers include, but are not limited to:
Adalvo will continue to grow their portfolio offerings in this domain, further highlighting our ability to offer differentiated, value-added products to our partners.
Partner Up Now!
At Adalvo, there are no half measures – we are always on target. When your mission is to be faster and stronger than your competitors, you need a winning team driving your vision forward.
arni.baldursson@adalvo.com - Head of Global BD&L
camila.reinoso@adalvo.com - LATAM (exc. Brazil)
marta.puig@adalvo.com - South Europe
ajish.rajan@adalvo.com – Central & Eastern Europe, Russia & CIS
jose.rendueles@adalvo.com- North Europe, APAC, MENA & Israel
marc.nolasco@adalvo.com - Central and Western Europe
paulo.rodriguez@adalvo.com – Europe
supreet.sharma@adalvo.com – UK/Ireland, North America & South Africa
Click on your preferred Business Partner and get in touch today!